Basic Information | Post buying leads | Suppliers |
Name |
Lynestrenol mixture with mestranol |
EINECS | N/A |
CAS No. | 8015-14-3 | Density | N/A |
PSA | 40.46000 | LogP | 8.78290 |
Solubility | N/A | Melting Point |
N/A |
Formula | C21H26O2•C20H28O | Boiling Point | 432.2°C at 760 mmHg |
Molecular Weight | 594.95 | Flash Point | 190.6°C |
Transport Information | N/A | Appearance | N/A |
Safety | Suspected human carcinogen producing liver tumors. An experimental teratogen. Human systemic effects by ingestion: dyspnea, nausea or vomiting, and fever. Experimental reproductive effects. Used as an oral contraceptive. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Noracycline |
The Synonyms name of Lynestrenol mixture with mestranol (CAS NO.8015-14-3):: CCRIS 7260 ; Lyndiol ; Lynestrenol mixed with mestranol ; Lynestrenol-mestranol ; Lynestrol mixed with mestranol ; Lynoestrenol mixed with mestranol ; Mestranol - lynestrenol mixture ; Mestranol mixed with lynestrenol ; Mestranol mixed with lynestrol ; Noracycline ; Ovanon ; Ovariostat ; Ovariostat [French] ; Restovar ; Sistometrenol
CAS: 8015-14-3
Molecular formula: C41H54O3
Molecular Weight: 594.95 g/mol
Molecular Structure:
The toxicity of Lynestrenol mixture with mestranol (CAS NO.8015-14-3):
1. | orl-wmn TDLo:32 mg/kg/130W-I:CAR,LIV | MJAUAJ Medical Journal of Australia. 2 (1978),223. | ||
2. | orl-wmn TD:104 mg/kg/10Y-I:NEO,LIV | MJAUAJ Medical Journal of Australia. 2 (1978),223. | ||
3. | orl-wmn TD:91 mg/kg/7Y-I:NEO,LIV | NPMDAD Nouvelle Presse Medicale. 5 (1976),3014. | ||
4. | orl-wmn TD:34 mg/kg/2Y-I:CAR,LIV | HEGAD4 Hepatogastroenterology. 29 (1982),187. | ||
5. | orl-wmn TDLo:22 mg/kg/2Y-I:PUL,GIT,MET | LANCAO Lancet. 1 (1973),1479. |
EPA Genetic Toxicology Program.
The safety information of Lynestrenol mixture with mestranol (CAS NO.8015-14-3):
Suspected human carcinogen producing liver tumors. An experimental teratogen. Human systemic effects by ingestion: dyspnea, nausea or vomiting, and fever. Experimental reproductive effects. Used as an oral contraceptive. When heated to decomposition it emits acrid smoke and irritating fumes.